Shortage Watch Free FDA drug-shortage watch

← all medications

Elbasvir; Grazoprevir Tablet

Brand names: Zepatier

Category: Antiviral

Not specified 1

FDA status: To Be Discontinued · Last FDA update: Oct 17, 2025 · First posted: Oct 17, 2025 · 1 manufacturers, 1 listed presentations

As of Oct 17, 2025, the FDA lists Elbasvir; Grazoprevir Tablet as being discontinued. Of 1 manufacturer presentations, 1 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Elbasvir; Grazoprevir Tablet is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
Presentation & package NDCManufacturerAvailabilityFDA note
Zepatier, Tablet, 50 mg; 100 mg (NDC 0006-3074-02)
NDC 0006-3074-02		 Merck Sharp & Dohme LLC Not specified To be discontinued December 1, 2025

Related medications in shortage

Other Antiviral medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Elbasvir; Grazoprevir Tablet (FDA data as of Oct 17, 2025). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Elbasvir; Grazoprevir Tablet. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Elbasvir; Grazoprevir Tablet.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/elbasvir-grazoprevir-tablet.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).